ACH underwent a massive corporate transformation, reducing revenue by 74% while swinging from positive to deeply negative stockholders' equity, indicating a major business restructuring or divestiture.
The company appears to have completed a fundamental business transformation, likely spinning off or selling its legacy Owens Minor distribution operations to focus solely on the patient direct healthcare services business (Apria and Byram Healthcare brands). This represents a complete strategic pivot that will require investors to reassess the company's business model, growth prospects, and financial profile as a pure-play home healthcare provider rather than a diversified healthcare supply chain company.
ACH's financials reflect a dramatic corporate transformation with revenue collapsing 74% from $10.7B to $2.8B and stockholders' equity turning deeply negative at -$461M. While operating income improved significantly to positive $27.5M, the company posted massive net losses of -$1.1B, and operating cash flow declined 78% to $161.5M. The substantial reduction in inventory (down 93%) and total assets (down 47%) confirms a major divestiture or spin-off of the legacy distribution business, fundamentally reshaping ACH into a smaller, home healthcare-focused entity.
Cash position surged 471% — strong cash generation or capital raise providing significant financial cushion.
Net income declined 203.5% — review whether driven by operations, interest costs, or non-recurring items.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Inventory drawn down 93.4% — strong sell-through or deliberate destocking; watch for supply constraints.
Operating cash flow fell 78.2% — earnings quality concerns; investigate working capital changes and non-cash items.
Revenue declined 74.2% — significant demand weakness or market share loss warrants investigation.
Current assets declined 72.9% — monitor working capital adequacy and short-term liquidity.
Current liabilities reduced — improved short-term financial position and working capital health.
Total assets contracted 47.3% — asset sales, write-downs, or balance sheet optimization underway.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →